PRESENTATION
The GTE--ENDOCAN TUTHYREF research grant was created by the ENDOCAN TUTHYREF network, in partnership with the GTE in 2023.
OBJECTIVE
The aim is to help fund translational or clinical research project(s) in the field of refractory thyroid cancer within the ENDOCAN-TUTHYREF network.
SOURCE OF FUNDS
Funds come from the pharmaceutical industry.
For 2023: EISAI (€20,000) and IPSEN (€20,000)
AMOUNT AND USE OF FUNDS
All funds raised each year are earmarked for this project. In the event of a project costing less than the total amount of a grant, the remaining budget will be retained for the following year's grant. The overall amount of aid provided each year is defined in advance by the ENDOCAN TUTHYREF steering committee. The maximum amount allocated to a project is also defined by the ENDOCAN TUTHYREF steering committee.
The amount of aid is paid to an organization, not to an individual. The recipient organization is responsible for settling any charges (social, insurance, etc.), which are included in the amount paid.
The GTE--ENDOCAN TUTHYREF research grant is not intended to finance hospitality, transportation, rent or other amenities that may be attributed to the lifestyle necessary for the winning candidate to carry out his or her research subject.
For the year 2023, the amount of the research fund is 40,000 Euros.
For the year 2023, 2 research projects will be funded:
One translational or clinical research project will be funded to the tune of 20,000 euros.
One translational or clinical research project will be funded to the tune of 20,000 euros.
JURY
The jury is made up of all the members of the ENDOCAN TUTHYREF steering committee. The main specialties are represented.
The Chairman of the Jury, appointed by the ENDOCAN TUTHYREF Steering Committee, has the casting vote.
Jury members involved in one of the submissions do not vote for that submission.
Entries will be evaluated according to the following criteria:
- Originality: /5
- Scientific interest: /5
- Methodology adapted to the question posed: /5
- Feasibility: /5
- Involvement of the ENDOCAN-TUTHYREF network in the project /5
- Relevance of funding to the project /5
Entries will be ranked according to the overall score obtained (/30) by each member of the jury.
A summary of the rankings is drawn up at the jury meeting. This meeting can be held in person, by telephone/Visio or electronically.
FILE CONSTITUTION
- Candidate
- No age limit
- Regardless of medical specialty
- The applicant or his/her team must be involved in the ENDOCAN-TUTHYREF network and be attached to an organization authorized to receive and manage the research grant.
- The applicant undertakes to mention the source of the ENDOCAN-TUTHYREF EWG grant in any oral or written publication.
- The candidate undertakes to provide an annual progress report and to present his or her results at the ENDOCAN
- TUTHYREF network's annual conference 2 years after receiving the grant.
- The candidate undertakes to write a report or scientific article.
- The applicant must be a member of the GTE or, failing that, have applied for membership prior to submission,
- Project eligibility criteria
- Refractory thyroid carcinomas (differentiated and/or medullary and/or anaplastic carcinomas)
- Clinical or translational research
- The project must not focus exclusively on the evaluation of a specific therapy.
- Research project involving the ENDOCAN-TUTHYREF network.
- Submission
- Applications must be submitted electronically.
- The dossier must be in the form of a single digital document containing all the elements requested, and must be sent by e-mail, as an attached document, to corberon@gustaveroussy.fr.
- The file (attached) must be drafted in accordance with the recommendations.
CALENDAR 2023
On-line date: end of June-beginning of July 2023, on the GTE website: http://www.reseau-gte.org and on the ENDOCAN-TUTHYREF website: https://www.tuthyref.com/
Application deadline: midnight Monday October 30, 2023,
Applications should be sent to the following address: corberon@gustaveroussy.fr.
Official presentation of the grant at the annual meeting of the ENDOCAN-TUTHYREF network on January 11 and 12, 2024.
Application and research project form 2023 - Recommendations PDF version
PDF version